Prostate Cancer Treatment in Kuala Lumpur:
Understanding Diagnosis, Treatment Options, and What to Expect
Being diagnosed with prostate cancer can feel overwhelming. Fortunately, many prostate cancers are detected early, and treatment options continue to advance. This guide explains how prostate cancer is diagnosed, how treatment decisions are made, and the different management options available, helping you have informed discussions with your urologist.
What Is Prostate Cancer?
Prostate cancer develops when cells within the prostate gland begin to grow abnormally. The prostate is a small gland located below the bladder that contributes fluid to semen.
It is one of the most common cancers affecting men worldwide. However, prostate cancer is not a single disease. Some prostate cancers grow so slowly that they may never cause symptoms or require treatment, while others are more aggressive and may spread if left untreated.
Understanding which type of prostate cancer you have is one of the most important steps in deciding whether treatment is needed and, if so, which treatment is most appropriate.
Modern imaging, improved biopsy techniques, and advances in treatment now allow doctors to tailor management according to the individual characteristics of the cancer rather than adopting a one-size-fits-all approach.
Symptoms of Prostate Cancer
Early prostate cancer often causes no symptoms at all, which is why it is frequently detected following an elevated PSA blood test or an abnormal prostate examination.
When symptoms do occur, they may include:
- Difficulty passing urine
- A weaker urinary stream
- Blood in the urine
- Blood in the semen
- Pain during ejaculation
- Persistent pain in the back, hips, or pelvis (in advanced disease)
- Unexplained weight loss or fatigue (less commonly)
It is important to remember that these symptoms are not specific to prostate cancer. Many men experience urinary symptoms because of an enlarged prostate (benign prostatic hyperplasia, or BPH), urinary tract infections, or other non-cancerous conditions.
A proper assessment is needed to determine the underlying cause.
How Is Prostate Cancer Diagnosed?
Diagnosing prostate cancer is a step-by-step process rather than relying on a single test.
Most patients progress through the following pathway:
Raised PSA or abnormal examination
↓
Clinical assessment and risk evaluation
↓
Multiparametric MRI of the prostate
↓
Transperineal prostate biopsy (when indicated)
↓
Gleason Grade Group and cancer staging
↓
Discussion of appropriate treatment options
Each step provides important information that helps determine whether cancer is present, how aggressive it appears, and whether treatment is required.
Understanding the Tests
PSA Blood Test
The prostate-specific antigen (PSA) blood test is often the first investigation that raises suspicion of prostate cancer.
Although PSA can be elevated in men with prostate cancer, it may also increase because of:
- Benign enlargement of the prostate
- Prostatitis
- Recent urinary infection
- Recent ejaculation
- Certain urological procedures
A raised PSA does not automatically mean cancer, nor does a normal PSA completely exclude it. The result must always be interpreted alongside your age, prostate size, symptoms, medical history, and examination findings.
Learn more: Raised PSA and Prostate Cancer Risk Assessment →
Prostate Health Index (PHI)
For some men with borderline or moderately elevated PSA levels, the Prostate Health Index (PHI) may provide additional information.
PHI combines several PSA-related measurements into a single score, helping estimate the likelihood of clinically significant prostate cancer. This may assist in deciding whether further investigations such as MRI or biopsy should be considered.
Learn more: Understanding the Prostate Health Index (PHI) →
Multiparametric MRI
MRI has become an important part of modern prostate cancer assessment.
A multiparametric MRI can identify suspicious areas within the prostate and provides valuable information before deciding whether a biopsy is necessary.
MRI may help:
- Detect suspicious lesions
- Estimate the likelihood of clinically significant cancer
- Guide targeted biopsies
- Assess whether cancer appears confined to the prostate
MRI findings are interpreted together with PSA levels and other clinical information.
Learn more: MRI for Prostate Cancer Assessment →
Transperineal Prostate Biopsy
If cancer is suspected after assessment, a prostate biopsy may be recommended.
Today, many centres perform biopsies through the transperineal approach, where biopsy needles pass through the skin between the scrotum and anus rather than through the rectum.
Compared with the traditional transrectal approach, transperineal biopsy significantly reduces the risk of serious infection while allowing accurate sampling of the prostate.
The biopsy provides the definitive diagnosis by determining:
- Whether cancer is present
- Gleason Grade Group
- Number of biopsy cores involved
- Extent of cancer within the prostate
Learn more: Transperineal Prostate Biopsy →
Understanding Your Diagnosis
Once prostate cancer has been confirmed, several factors help determine the most appropriate treatment.
These include:
- PSA level
- MRI findings
- Gleason Grade Group
- Clinical stage
- Whether the cancer appears confined to the prostate
- Overall health
- Age
- Existing urinary symptoms
- Personal priorities regarding urinary continence, sexual function, and recovery
Not every man with prostate cancer requires immediate treatment. For some patients with carefully selected low-risk disease, active surveillance may be the safest and most appropriate option.
If your PSA is elevated but you have not yet undergone further assessment, you may also find our guide to Raised PSA and Prostate Cancer Risk Assessment helpful.
Treatment Options for Prostate Cancer
There is no single “best” treatment for prostate cancer. The most appropriate option depends on the characteristics of the cancer and the individual patient’s circumstances.
Modern treatment options include:
| Treatment | May be considered for |
|---|---|
| Active Surveillance | Selected low-risk prostate cancer |
| Robotic Radical Prostatectomy | Localised prostate cancer |
| HIFU (High-Intensity Focused Ultrasound) | Carefully selected localised cancers |
| Irreversible Electroporation (IRE) | Selected focal prostate cancers |
| Radiotherapy | Localised and some locally advanced cancers |
| Hormonal Therapy | Often combined with radiotherapy or used in advanced disease |
| Chemotherapy or targeted therapies | Selected advanced prostate cancers |
Each option has potential benefits, limitations, and possible side effects. Treatment decisions should be individualised after careful discussion with your treating team.
Active Surveillance
Not every prostate cancer needs immediate treatment.
For carefully selected men with low-risk disease, active surveillance involves closely monitoring the cancer through PSA testing, repeat MRI scans, and, when appropriate, repeat biopsies.
The aim is to avoid or delay treatment while still identifying any signs that the cancer is becoming more aggressive.
Robotic Radical Prostatectomy
Robotic-assisted radical prostatectomy removes the entire prostate gland together with the cancer.
For suitable patients with localised prostate cancer, robotic surgery offers a minimally invasive approach using small incisions and magnified three-dimensional vision.
Potential advantages may include:
- Smaller incisions
- Reduced blood loss
- Earlier mobilisation
- Shorter hospital stay
- Faster recovery compared with traditional open surgery
When appropriate, nerve-sparing techniques may also be considered to help preserve erectile function.
Related resources
Focal Therapy
For carefully selected men with localised prostate cancer, focal therapy aims to treat only the area containing clinically significant cancer while preserving as much healthy prostate tissue as possible.
The two main focal therapies offered include:
High-Intensity Focused Ultrasound (HIFU)
HIFU uses precisely focused ultrasound energy to destroy cancerous tissue without surgical incisions.
Learn more: HIFU for Prostate Cancer →
Irreversible Electroporation (IRE)
IRE uses short electrical pulses to destroy cancer cells while preserving surrounding connective tissue.
It may be considered for selected cancers located in areas where preservation of nearby structures is particularly important.
Learn more: Irreversible Electroporation (IRE) →
Radiotherapy
Radiotherapy uses carefully planned high-energy radiation to destroy prostate cancer cells.
Depending on the stage of cancer, radiotherapy may be used:
- As the primary treatment
- Together with hormonal therapy
- Following surgery in selected patients
Some patients receiving radiotherapy may also benefit from a rectal spacer to reduce radiation exposure to the rectum.
Related resources
Hormonal Therapy
Prostate cancer cells often depend on testosterone for growth.
Hormonal therapy lowers testosterone levels or blocks its effects on prostate cancer cells.
It may be used:
- Together with radiotherapy
- Before radiotherapy
- For recurrent prostate cancer
- For advanced or metastatic disease
Treatment plans vary depending on the stage of cancer and overall treatment goals.
Learn more: Hormonal Therapy for Prostate Cancer →
Advanced Prostate Cancer
If prostate cancer has spread beyond the prostate, treatment focuses on controlling the disease, reducing symptoms, and maintaining quality of life.
Depending on the individual situation, management may include:
- Hormonal therapy
- Chemotherapy
- PSMA-targeted therapy
- Bone-strengthening medications
- Supportive care
Advances in treatment continue to improve outcomes for many patients with advanced prostate cancer.
Choosing the Right Treatment
Choosing treatment involves balancing cancer control with quality of life.
Your doctor will consider:
- Cancer stage
- Gleason Grade Group
- PSA level
- MRI findings
- General health
- Life expectancy
- Existing urinary symptoms
- Recovery goals
- Personal preferences
For many men, there is time to understand the diagnosis, ask questions, and discuss the available options before making a decision.
A Multidisciplinary Approach to Care
Prostate cancer treatment often involves collaboration between different healthcare professionals.
Depending on your diagnosis, your care may include input from:
- Consultant urologists
- Clinical oncologists
- Radiologists
- Pathologists
- Specialist nurses
- Other healthcare professionals involved in cancer care
Working together allows investigations, imaging, and treatment recommendations to be reviewed comprehensively so that management is tailored to your individual situation.
Learn more: One-Stop Prostate Cancer Care →
Frequently Asked Questions
Is prostate cancer always life-threatening?
No. Many prostate cancers grow slowly and may never become life-threatening. Others are more aggressive and require timely treatment. The behaviour of the cancer depends on its grade, stage, and other clinical factors.
Can prostate cancer be cured?
Many men with localised prostate cancer can be treated with curative intent. The most appropriate treatment depends on the characteristics of the cancer and the individual patient.
Is robotic surgery better than radiotherapy?
Neither treatment is universally better. Both are established treatment options for suitable patients. The choice depends on factors such as the stage of cancer, age, overall health, and personal priorities.
Can focal therapy replace surgery?
Focal therapy may be appropriate for carefully selected patients with localised prostate cancer. It is not suitable for everyone, and eligibility depends on MRI findings, biopsy results, and the location and extent of the cancer.
Do all men with prostate cancer need immediate treatment?
No. Some men with carefully selected low-risk prostate cancer may be suitable for active surveillance rather than immediate treatment.
Can I seek a second opinion?
Yes. Many patients choose to seek a second opinion before making treatment decisions. Understanding your diagnosis and discussing the available options can help you feel more confident about your treatment plan.
How long does prostate cancer treatment usually take?
The duration of prostate cancer treatment depends on the type of treatment recommended.
- Active surveillance involves regular PSA tests, follow-up consultations, MRI scans, and occasionally repeat biopsies over time rather than immediate treatment.
- Robotic radical prostatectomy is usually performed as a single operation, with recovery continuing over the following weeks and regular follow-up appointments to monitor PSA levels.
- Focal therapies such as HIFU or IRE are typically completed in a single treatment session, followed by scheduled PSA tests, MRI scans, and clinical reviews.
- Radiotherapy is usually delivered over several treatment sessions, often over a number of weeks, and may be combined with hormonal therapy depending on the stage of the cancer.
- Hormonal therapy for advanced or locally advanced prostate cancer may continue for months or longer, depending on the treatment plan.
Regardless of the treatment chosen, regular follow-up is an important part of prostate cancer care to monitor recovery, PSA levels, and long-term outcomes.
Discussing Your Treatment Options
Every prostate cancer diagnosis is unique. Understanding your PSA level, MRI findings, biopsy results, and overall health helps guide treatment decisions.
If you have recently been diagnosed with prostate cancer or have been advised that further assessment is needed, discussing your results with a urologist can help clarify your diagnosis, explain the available treatment options, and support you in making an informed decision about your care.